Protective activity of probiotic bacteria against 2-amino-3-methyl-3H-imidazo[4,5-f]quinoline (IQ) and 2-amino-1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridine (PhIP) – an in vitro study

Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment

Volumn 32, Issue 11, 2015, Pages 1927-1938

  Nowak, Adriana ^a   Czyżowska, Agata ^a   Stańczyk, Małgorzata ^b  

^a LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

cytotoxicity; DNA damage; heterocyclic aromatic amines; HPLC; probiotics

Indexed keywords

AMINES; AROMATIC COMPOUNDS; DNA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; NUTRITION; ORGANIC COMPOUNDS; PYRIDINE; THERMAL PROCESSING (FOODS);

ANTI OXIDATIVE ACTIVITY; CARCINOGENIC COMPOUNDS; DNA DAMAGES; GASTROINTESTINAL TRACT; HETEROCYCLIC AROMATIC AMINE (HAAS); HETEROCYCLIC AROMATIC AMINES; HPLC; PROBIOTICS;

CYTOTOXICITY;

2 AMINO 1 METHYL 6 PHENYL 1H IMIDAZO[4,5 B]PYRIDINE; 2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; ANTIOXIDANT; CARCINOGEN; CYTOPROTECTIVE AGENT; PROBIOTIC AGENT; UNCLASSIFIED DRUG; 2-AMINO-1-METHYL-6-PHENYL-1H-IMIDAZO(4,5-B)PYRIDINE; 2-AMINO-3-METHYL-3H-IMIDAZO(4,5-F)QUINOLINE; AMINOPYRIDINE DERIVATIVE; IMIDAZOLE DERIVATIVE; QUINOLINE DERIVATIVE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CELL VIABILITY; CHILD; COLON ADENOCARCINOMA; COMET ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; FECES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE FLORA; LACTIC ACID BACTERIUM; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ADOLESCENT; CELL SURVIVAL; CHEMISTRY; INFANT; LACTOBACILLUS; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINOPYRIDINES; CELL SURVIVAL; CHILD; CHILD, PRESCHOOL; FECES; GASTROINTESTINAL MICROBIOME; HUMANS; IMIDAZOLES; INFANT; LACTOBACILLUS; PROBIOTICS; QUINOLINES; YOUNG ADULT;

EID: 84945496136     PISSN: 19440049     EISSN: 19440057     Source Type: Journal    
DOI: 10.1080/19440049.2015.1084651     Document Type: Article

References (51)

1. [IARC] International Agency for Research on Cancer. 1993. Monographs on the evaluation of carcinogenic risks to human: some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. Vol. 56. Lyon, France: World Health Organisation; p. 165–229.
2. [IARC] International Agency for Research on Cancer. 1994. Monographs on the evaluation of carcinogenic risks to human: some industrial chemicals. Vol. 60. Lyon, France: World Health Organisation; p. 389–433.
3. A.Bartoszek 2007. Mutagenic, carcinogenic, and chemopreventive compounds in foods. In: S.Ze, editor. Chemical and functional properties of food components. Boca Raton: CRC Press, Taylor & Francis Group; p. 451–485.
4. S.Bawa. 2008. The role of diet and nutrition in the prevention of cancer. In: N.E.Bernhardt, A.M.Kasko, editors. Nutrition for the middle aged and elderly. New York (NY): Nova Science Publishers; p. 107–156.
5. J.Blasiak, M.Arabski, R.Krupa, K.Wozniak, M.Zadrozny, J.Kasznicki, M.Zurawska, J.Drzewoski. 2004. DNA damage and repair in type 2 diabetes mellitus. Mutat Res. 554:297–304.
6. J.Błasiak, J.Kowalik. 2000. A comparison of the in vitro genotoxicity of tri- and hexavalent chromium. Mutat Res. 469:135–145.
7. F.Bolognani, C.J.Rumney, I.R.Rowland. 1997. Influence of carcinogen binding by lactic acid producing bacteria on tissue distribution and in vivo mutagenicity of dietary carcinogens. Food Chem Toxicol. 35:535–545.
8. E.M.Brown, C.Latimer, P.Allsopp, N.G.Ternan, G.McMullan, G.J.McDougall, D.Stewart, A.Crozier, I.R.Rowland, C.I.R.Gill. 2014. In vitro and in vivo models of colorectal cancer: antigenotoxic activity of berries. J Agric Food Chem. 62:3852–3866.
9. C.K.Chakraborti. 2011. The status of synbiotics on colorectal cancer. Life Sci Med Res. 20:1–14.
10. B.Cukrowska, I.Motyl, H.Kozáková, M.Schwarzer, R.K.Górecki, E.Klewicka, K.Śliżewska, Z.Libudzisz. 2009. Probiotic Lactobacillus strains: in vitro and in vivo studies. Folia Microbiol. 54:533–537.
11. B.Cukrowska, I.Rosiak, E.Klewicka, I.Motyl, M.Schwarzer, Z.Libudzisz, H.Kozakova. 2010. Impact of heat-inactivated Lactobacillus casei and Lactobacillus paracasei strains on cytokine responses in whole blood cell cultures of children with atopic dermatitis. Folia Microbiolo. 55:277–280.
12. T.M.C.M.de Kok, A.Van Faassen, B.Glinghammar, D.M.F.A.Pachen, J.J.Rafter, C.G.M.I.Baeten, L.G.J.B.Engels, J.C.S.Kleinjans. 1999. Bile acid concentrations, cytotoxicity, and pH of fecal water from patients with colorectal adenomas. Di Dis Sci. 44:2218–2225.
13. L.Dominici, M.Villarini, F.Trotta, E.Federici, G.Cenci, M.Moretti. 2014. Protective effects of probiotic Lactobacillus rhamnosus IMC501 in mice treated with PhIP. J Microbiol Biotechnol. 24:371–378.
14. F.Faridnia, A.Hussin, N.Saari, S.Mustafa, L.Y.Yee, M.Y.A.Manap. 2010. In vitro binding of mutagenic heterocyclic aromatic amines by Bifidobacterium pseudocatenulatum G4. Benef Microbes. 1:149–154.
15. L.R.Ferguson. 2010. Meat and cancer. Meat Sci. 84:308–313.
16. B.Glinghammar, M.Venturi, I.R.Rowland, J.J.Rafter. 1997. Shift from a dairy product-rich to a dairy product-free diet: influence on cytotoxicity and genotoxicity of fecal water – potential risk for colon cancer. Am JClin Nutr. 66:1277–1282.
17. R.Hughes, I.R.Rowland. 2000. Metabolic activities of the gut microflora in relation to cancer. Microb. Ecol Health Dis. 12:179–185.
18. P.C.Karlsson. 2005. Biomarkers for colon cancer: applications in human and rat studies. Stockholm, Sweden: Department of Medical Nutrition, Karlinska Institutet.
19. G.A.Keating, K.T.Bogen. 2004. Estimates of heterocyclic amine intake in the US population. J Chromatogr B. 802:127–133.
20. Keating GA, Bogen KT, Chan JM. 2007. Development of a meat frequency questionnaire for use in diet and cancer studies. J Am Diet Assoc. 107:1356–1362.
21. V.J.Koller, B.Marian, R.Stidl, A.Nersesyan, H.Winter, T.Simić, G.Sontag, S.Knasmüller. 2008. Impact of lactic acid bacteria on oxidative DNA damage in human derived colon cells. Food Chem Toxicol. 46:1221–1229.
22. G.G.C.Kuhnle, A.A.Bingham. 2010. Meats, protein and cancer. In: J.A.Milner, R.Df, A.Ds, M.Lluria-Prevatt, L.Sm, editors. Bioactive compounds and cancer. New York, NY: Humana Press, Springer Science+Business Media; p. 195–212.
23. M.Kumar, R.Nagpal, V.Verma, A.Kumar, N.Kaur, R.Hemalatha, S.K.Gautam, B.Singh. 2012. Probiotic metabolites as epigenetic targets in the prevention of colon cancer. Nutr Rev. 71:23–34.
24. M.Llana-Ruiz-Cabelloa, D.Gutiérrez-Praena, S.Pichardo, F.J.Moreno, J.M.Bermúdez, S.Aucejo, A.M.Cameán. 2014. Cytotoxicity and morphological effects induced by carvacrol and thymol on the human cell line Caco-2. Food Chem Toxicol. 64:281–290.
25. M.Murata, M.Kobayashi, S.Kawanish. 1999. Mechanism of oxidative DNA damage induced by a heterocyclic amine, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Jpn J Cancer Res. 90:268–275.
26. A.Nowak. 2014. Growth and survival of probiotic lactic acid bacteria in the presence of heterocyclic aromatic amines. ŻYWNOŚĆ – Nauka, Technologia, Jakość. 3:56–64. Article in English – free access.
27. A.Nowak, Śliżewska K, Klewicka E. 2012. Effect of probiotic lactobacilli on faecal enzyme and genotoxic activity in human faecal water in the presence of the carcinogen PhIP in vitro. Int J Dairy Technol. 65:300–307.
28. A.Nowak, Z.Libudzisz. 2009. Ability of probiotic Lactobacillus casei DN 114001 to bind or/and metabolise heterocyclic aromatic amines in vitro. Eur J Nutr. 48:419–427.
29. A.Nowak, K.Śliżewska. 2014. β-glucuronidase and β-glucosidase activity and human fecal water genotoxicity in the presence of probiotic lactobacilli and the heterocyclic aromatic amine IQ in vitro. Environ Toxicol Pharmacol. 37:66–73.
30. A.Nowak, K.Śliżewska, J.Błasiak, Z.Libudzisz. 2014. The influence of Lactobacillus casei DN 114 001 on the activity of faecal enzymes and genotoxicity of faecal water in the presence of heterocyclic aromatic amines. Anaerobe. 30:129–136.
31. S.T.Omaye. 2004. Food and nutritional toxicology. Chapter 19, Boca Raton, FL: CRC Press.
32. K.Orrhage, E.Sillerström, J.-Å.Gustafsson, C.E.Nord, J.Rafter. 1994. Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria. Mutat Res. 311:239–248.
33. K.Osswald, T.W.Becker, M.Grimm, G.Jahreis, B.L.Pool-Zobel. 2000. Inter- and intra-individual variation of faecal water – genotoxicity in human colon cells. Mutat Res. 472:59–70.
34. M.Pezdirc, B.Žegura, M.Filipič. 2013. Genotoxicity and induction of DNA damage responsive genes by food-borne heterocyclic aromatic amines in human hepatoma HepG2 cells. Food Chem Toxicol. 59:386–394.
35. K.L.Platt, R.Edenharder, S.Aderhold, E.Muckel, H.Glatt. 2010. Fruits and vegetables protect against the genotoxicity of heterocyclic aromatic amines activated by human xenobiotic-metabolizing enzymes expressed in immortal mammalian cells. Mutat Res. 703:90–98.
36. M.A.Rieger, A.Parlesak, B.L.Pool-Zobel, G.Rechkemmer, C.Bode. 1999. A diet high in fat and meat but low in dietary fibre increases the genotoxic potential of `faecal water’. Carcinogenesis. 20:2311–2316.
37. M.Rondanelli, A.Giacosa, M.A.Faliva, S.Perna, F.Allieri, A.M.Castellazzi. 2015. Review on microbiota and effectiveness of probiotics use in older. World J Clin Cases. 3:156–162.
38. K.Sivieri, R.Bedani, D.Cavallini, E.U.Rossi. 2013. Probiotics and intestinal microbiota: implications in colon cancer prevention. In: M.Kongo, editor. Lactic acid bacteria – R & D for food, health and livestock purposes. Rijeka: InTech Open Access.
39. A.W.Speedy. 2003. Global production and consumption of animal source foods. J Nutr. 133:4048S–4053S.
40. O.Sreekumar, A.Hosono. 1998a. Antimutagenicity and the influence of physical factors in binding lactobacillus gasseri and Bifidobacterium longum cells to amino acid pyrolysates. J Dairy Sci. 81:1508–1516.
41. O.Sreekumar, A.Hosono. 1998b. The antimutagenic properties of a polysaccharide produced by Bifidobacterium longum and its cultured milk against some heterocyclic amines. Can. J Microbiol. 44:1029–1036.
42. R.Stidl, G.Sontag, V.Koller, S.Knasmüller. 2008. Binding of heterocyclic aromatic amines by lactic acid bacteria: results of a comprehensive screening trial. Mol Nutr Food Res. 52:322–329.
43. H.Tsuda, K.Hara, T.Miyamoto. 2008. Binding of mutagens to exopolysaccharide produced by Lactobacillus plantarum mutant strain 301102S. J Dairy Sci. 91:2960–2966.
44. R.J.Turesky, M.L.LeMarchand L. 2011. Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines. Chem Res Toxicol. 24:1169–1214.
45. M.Uccello, G.Malaguarnera, F.Basile, V.D’agata, M.Malaguarnera, G.Bertino, M.Vacante, F.Drago, A.Biondi. 2012a. Potential role of probiotics on colorectal cancer prevention. Surgery. 12:S35.
46. M.Uccello, G.Malaguarnera, T.Corriere, A.Biondi, F.Basile, M.Malaguarnera. 2012b. Risk of hepatocellular carcinoma in workers exposed to chemicals. Hepat Mon. 12:e5943.
47. M.Uccello, G.Malaguarnera, P.Em, A.Biondi, F.Basile, M.Motta. 2011. Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinoma. Indian J Med Paediatr Oncol. 32:71–75.
48. P.Vitaglione, V.Fogliano. 2004. Use of antioxidants to minimize the human health risk associated to mutagenic/carcinogenic heterocyclic amines in food. J Chromatogr B. 802:189–199.
49. N.Voreades, A.Kozil, T.L.Weir. 2014. Diet and the development of the human intestinal microbiome. Front Microbiol. 5:494.
50. G.E.Walton, G.R.Gibson. 2010. Gut microbiota, probiotics, prebiotics and colorectal cancer. In: J.A.Milner, R.Df, A.Ds, M.Lluria-Prevatt, L.Sm, editors. Bioactive compounds and cancer. New York, NY: Humana Press, Springer Science+Business Media; p. 181–193.
51. H.Zhao, F.Zhou, Y.Qi, P.Dziugan, F.Bai, P.Walczak, B.Zhang. 2013. Screening of Lactobacillus strains for their ability to bind benzo(a)pyrene and the mechanism of the process. Food Chem Toxicol. 59:67–71.